Manu Chakravarthy

Manu Chakravarthy

Company: Roche

Job title: SVP and Global Head of Cardiovascular, Renal and Metabolism Product Development

Seminars:

Workshop B: An Understanding of Insulin Resistance, Implications to MASH Pathophysiology 9:00 am

New treatment options are provided by a combination of incretins and insulin sensitizers Insulin sensitizing pharmacology impacts the underlying MASH pathology providing a new understanding of the underlying pathology Incretin treatments impact more than underlying obesity and also provide unique opportunities in combination with insulin sensitizers A round table discussion will discuss which features of…Read more

day: Pre Conf Workshop Day - Clinical & Regulatory Track

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.